Correlation Between ImmunoCellular Therapeutics and Genenta Science

Can any of the company-specific risk be diversified away by investing in both ImmunoCellular Therapeutics and Genenta Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmunoCellular Therapeutics and Genenta Science into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ImmunoCellular Therapeutics and Genenta Science SpA, you can compare the effects of market volatilities on ImmunoCellular Therapeutics and Genenta Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmunoCellular Therapeutics with a short position of Genenta Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmunoCellular Therapeutics and Genenta Science.

Diversification Opportunities for ImmunoCellular Therapeutics and Genenta Science

0.0

Correlation Coefficient

ImmunoCellular Therapeutics  Genenta Science

Pay attention - limited upside

The 3 months correlation between ImmunoCellular and Genenta is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoCellular Therapeutics and Genenta Science SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genenta Science SpA and ImmunoCellular Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmunoCellular Therapeutics are associated (or correlated) with Genenta Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genenta Science SpA has no effect on the direction of ImmunoCellular Therapeutics i.e., ImmunoCellular Therapeutics and Genenta Science go up and down completely randomly.

Pair Corralation between ImmunoCellular Therapeutics and Genenta Science

If you would invest (100.00) in ImmunoCellular Therapeutics on December 29, 2024 and sell it today you would earn a total of  100.00  from holding ImmunoCellular Therapeutics or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

ImmunoCellular Therapeutics  vs.  Genenta Science SpA

ImmunoCellular Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days ImmunoCellular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, ImmunoCellular Therapeutics is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Genenta Science SpA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Genenta Science SpA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Genenta Science is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with ImmunoCellular Therapeutics and Genenta Science

The main advantage of trading using opposite ImmunoCellular Therapeutics and Genenta Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmunoCellular Therapeutics position performs unexpectedly, Genenta Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genenta Science will offset losses from the drop in Genenta Science's long position.

The idea behind ImmunoCellular Therapeutics and Genenta Science SpA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.